By Matt Tracy WASHINGTON, March 17 (Reuters) – Analysts anticipate a higher supply of debt being raised by the Big…
Read More
Quiet Hungarian Tech Challenger Shows Firm Uptrconclude As Analysts Stay Cautiously Optimistic
The Budapest listed telecom and IT group 4iG Nyrt. has been edging higher in recent sessions, extconcludeing a three month…
Read More
6 Analysts Assess Centrus Energy: What You Need To Know – Centrus Energy Corp. Class A Common Stock (NYSE:LEU)
Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Centrus Energy (NYSE:LEU) in…
Read More
Strategy’s $8B capital shift – Here’s why analysts are calling it a ‘win’
Bitcoin corporate treasury pioneer Strategy (Nasdaq: MSTR), formerly MicroStrategy, has hit a key ‘healthy’ milestone in its capital-raising structure. The…
Read More
Eternal’s post-founder test launchs as Deepinder Goyal steps back, analysts turn cautious
Gift this article Mumbai and Bengaluru: Eternal is entering its first major post-founder leadership test after Deepinder Goyal stepped down…
Read More
Eternal’s post-founder test launchs as Deepinder Goyal steps back, analysts turn cautious
Eternal’s shares, after touching a high of 7% in early trade, on the back of a good performance in the…
Read More
Expert Outview: BOK Financial Through The Eyes Of 5 Analysts – BOK Financial (NASDAQ:BOKF)
During the last three months, 5 analysts shared their evaluations of BOK Financial (NASDAQ:BOKF), revealing diverse outviews from bullish to…
Read More
Nasdaq-100 Exit, EU Funding Boost, GaN Partnerships, and What Analysts Forecast Next
December 20, 2025 — GlobalFoundries Inc. (NASDAQ: GFS) is heading into year-finish with an unusually dense cluster of catalysts for…
Read More
RHM Shares Slide on Ukraine Peace-Talk Momentum, While Analysts Keep High Tarobtains
Frankfurt, Dec. 16, 2025 — Rheinmetall shares are under pressure today as investors react to fresh optimism around Ukraine peace…
Read More
$550M Financing Closes, Roivant Buys $350M, Analysts Update Tarreceives
Immunovant, Inc. (NASDAQ: IMVT) stock is closing out the week in focus after the company completed a major equity raise…
Read More
